Study record

Insights into the Biomarker Potential of Humanin and Mots-c Expression and Telomere Length in Alzheimer's Disease

Rodríguez-Esparragón F, Cazorla-Rivero SE, Torrealba E et al. · Int J Mol Sci · 2025

Human obs.SeveralEvidence tier BAlso: Analytical / methods

What this study reported

Reported that blood and plasma transcript levels of humanin and MOTS-c, normalised to mitochondrial DNA copy number, differed significantly across groups and were lower in adults with Alzheimer's disease than in those with subjective cognitive decline. Found that plasma protein concentrations of the two peptides did not distinguish Alzheimer's disease from mild cognitive impairment. Reported in decay assays faster degradation of humanin mRNA and delayed but stable recovery of MOTS-c mRNA.

Limitations

Cross-sectional case-control comparison with no group sizes reported in the abstract, controls defined as subjective cognitive decline rather than healthy individuals, and transcript-level findings not corroborated by circulating protein measurements.

Study record

Annotated fields for this study
Study modelHuman observational
Substance studiedSeveralMore than one of these is central to the paper (common for reviews).
Specieshuman
System studiedPatients with Alzheimer's disease or mild cognitive impairment and individuals with subjective cognitive decline as controls
Populationolder adults with Alzheimer's disease, mild cognitive impairment, or subjective cognitive decline
DesignCase-control study with in silico and RNA decay assays
Sample size as reportedNot reported
Control groupindividuals with subjective cognitive decline
Route (data field only)Not reported
Endpoints measuredblood and plasma MOTS-c transcript levels; plasma MOTS-c protein concentration; humanin transcript and protein levels; mitochondrial DNA copy number; mRNA decay kinetics
Pathways measuredNot reported
Research areasNervous system · Aging · Mitochondrial biology
Evidence tierB — Other human study
Publication typesJournal Article

Appraisal

Each dimension is recorded separately and never combined into a single score. A study can be well controlled and still tell you little about people.

Relevance to MOTS-c
Direct
Model applicability
Human
Sample size
Not reported
Controls
Limited
Outcome validity
Exploratory
Support for its own conclusion
Moderate

Provenance

  • Bibliographic fields retrieved from PubMed E-utilities efetch (title, journal, date, authors, DOI) on 2026-11-11.
  • Annotated from the published abstract.
  • Editorial review: approved (2026-11-11).
  • Classification follows the site methodology; the record describes the study, not what MOTS-c does in people.